Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

被引：0
|
作者：
Hara Kousoulakou
Magdalini Hatzikou
Varvara Baroutsou
John Yfantopoulos
机构：
[1] University of Peloponnese,
[2] Novartis Hellas SACI,undefined
[3] National and Kapodistrian University of Athens,undefined
[4] School of Economics and Political Science ,undefined
来源：
Cost Effectiveness and Resource Allocation | / 15卷
关键词：
Vildagliptin; Type 2 diabetes mellitus; Cost-effectiveness; Greece;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
    Kousoulakou, Hara
    Hatzikou, Magdalini
    Baroutsou, Varvara
    Yfantopoulos, John
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
  • [2] ECONOMIC EVALUATION OF VILDAGLIPTIN COMPARED TO GLIMEPIRIDE AS ADD-ON TO METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 PATIENTS IN GREECE
    Hatzikou, M.
    Rombopoulos, G.
    Yfantopoulos, J.
    VALUE IN HEALTH, 2012, 15 (07) : A501 - A501
  • [3] COST-EFFECTIVENESS ANALYSIS OF VILDAGLIPTIN VS. GLIMEPIRIDE AS ADD-ON TO METFORMIN IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN GREECE
    Kousoulakou, H.
    Kalogeropoulou, M.
    Panitti, E.
    VALUE IN HEALTH, 2015, 18 (07) : A608 - A608
  • [4] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Nicholas Tentolouris
    Georgia Kourlaba
    Nikos Maniadakis
    Clinical Drug Investigation, 2016, 36 : 649 - 659
  • [5] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Tzanetakos, Charalampos
    Tentolouris, Nicholas
    Kourlaba, Georgia
    Maniadakis, Nikos
    CLINICAL DRUG INVESTIGATION, 2016, 36 (08) : 649 - 659
  • [6] COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Tzanetakos, C.
    Tentolouris, N.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A607
  • [7] The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus
    Charokopou, M.
    McEwan, P.
    Lister, S.
    Callan, L.
    Bergenheim, K.
    Tolley, K.
    Postema, R.
    Townsend, R.
    Roudaut, M.
    DIABETIC MEDICINE, 2015, 32 (07) : 890 - 898
  • [8] COST-EFFECTIVENESS ANALYSIS OF LINAGLIPTIN VERSUS SULFONYLUREA AS ADD-ON TREATMENT TO METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 PATIENTS IN INDONESIA
    Endarti, D.
    Kristin, E.
    Pratiwi, W. R.
    Pinzon, R. T.
    Nugrahaningsih, D. A.
    Yasmina, A.
    Febrinasari, R. P.
    VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [9] Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients
    Cakirca, Mustafa
    Karatoprak, Cumali
    Zorlu, Mehmet
    Kiskac, Muharrem
    Kanat, Mustafa
    Cikrikcioglu, Mehmet Ali
    Soysal, Pinar
    Hursitoglu, Mehmet
    Camli, Ahmet Adil
    Erkoc, Reha
    Abdul-Ghani, Muhammad
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 239 - 243
  • [10] Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
    Kikuchi, Masatoshi
    Haneda, Masakazu
    Koya, Daisuke
    Tobe, Kazuyuki
    Onishi, Yukiko
    Couturier, Andre
    Mimori, Nobuyuki
    Inaba, Yoko
    Goodman, Matthew
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (03) : 216 - 223
12345